Black Rock Inc. Allovir, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Allovir, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 634,020 shares of ALVR stock, worth $6.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
634,020
Previous 3,385,831
81.27%
Holding current value
$6.22 Million
Previous $2.57 Million
82.28%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ALVR
# of Institutions
3Shares Held
727KCall Options Held
0Put Options Held
0About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $913M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...